This metabolic reprogramming of pancreatic cancer is mainly mediated by mutant KRAS (KRAS∗), and that oncogenic KRAS∗ is the signature genetic event for pancreatic cancer progression.14 The gene discussed is KRAS; the disease is pancreatic neoplasm.